Peptide-based vaccine targeting IL17A attenuates experimental spondyloarthritis in HLA-B27 transgenic rats.

Hiroki HayashiJiao SunYuka YanagidaShota YoshidaSatoshi BabaAkiko TenmaMasayoshi ToyouraSotaro KawabataTakako EharaRyoko AsakiMakoto SakaguchiHideki TomiokaMunehisa ShimamuraRyuichi MorishitaHiromi RakugiTetsuya TomitaHironori Nakagami

Published in: RMD open (2023)

IL17A peptide-based vaccine may be a therapeutic option for SpA treatment.

Keyphrases

ankylosing spondylitis
disease activity
rheumatoid arthritis
drug delivery
replacement therapy